Research map: Is there a Role for Rezafungin in Intra-Abdominal Candida spp. Infections? A Case Series and Literature Review

Back to the article

Papers in this map

  1. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project · Matteo Bassetti · 2019 · 275 citations · Cited by this paper
  2. Phaeohyphomycosis caused by Exophiala oligosperma in liver transplant recipient: case report and literature review · 2025 · Related
  3. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts · Matteo Bassetti · 2013 · 199 citations · Cited by this paper
  4. Trichophyton tonsurans infections in North Africa: A case series from Tunisia · 2026 · Related
  5. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial · George R. Thompson · 2022 · 185 citations · Cited by this paper
  6. Fungal infection does not impair flow cytometry signals induced by nCD64 and mCD169 biomarkers during co-infection with bacteria and viruses · 2025 · Related
  7. Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial · George R. Thompson · 2020 · 162 citations · Cited by this paper
  8. Ketoconazole-loaded microspone film coating agent for superficial fungal infection: design, preparation and characterization · 2025 · Related
  9. Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment · Paschalis I. Vergidis · 2016 · 150 citations · Cited by this paper
  10. Oral Candida infection and colonization in pediatric patients with cancer: risk factors, species distribution, and antifungal susceptibility · 2026 · Related
  11. Rezafungin—Mechanisms of Action, Susceptibility and Resistance: Similarities and Differences with the Other Echinocandins · Guillermo García‐Effrón · 2020 · 131 citations · Cited by this paper
  12. Performance of recombinase polymerase amplification-based assay (RPA) for rapid detection of fungal pathogens in clinical samples of patients in Abidjan, Côte d’Ivoire · 2025 · Related
  13. Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model · Yanan Zhao · 2017 · 103 citations · Cited by this paper
  14. Seborrheic dermatitis and dandruff: An overview of pathogenesis, role of Malassezia spp., and natural treatment approaches · 2026 · Related
  15. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials · George R. Thompson · 2023 · 82 citations · Cited by this paper
  16. Mycological and epidemiological study of dermatophytosis due to Trichophyton rubrum among patients of the Mohammed VI University Hospital of Oujda, Morocco (2020-2024) · 2026 · Related
  17. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study · Matteo Bassetti · 2022 · 55 citations · Cited by this paper
  18. Long-term treatment outcomes among AIDS patients with and without talaromycosis: A retrospective study · 2025 · Related
  19. Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data · Yanan Zhao · 2020 · 51 citations · Cited by this paper
  20. Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy · Lynn Miesel · 2019 · 48 citations · Cited by this paper
  21. Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia · Lynn Miesel · 2020 · 44 citations · Cited by this paper
  22. Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin · Alessandra Oliva · 2023 · 36 citations · Cited by this paper
  23. Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations · Shawn D. Flanagan · 2023 · 24 citations · Cited by this paper
  24. The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics · David R. Andes · 2024 · 23 citations · Cited by this paper
  25. Population Pharmacokinetics of Rezafungin in Patients with Fungal Infections · Christopher M. Rubino · 2021 · 21 citations · Cited by this paper
  26. Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials · Patrick M. Honoré · 2024 · 20 citations · Cited by this paper
  27. Rezafungin in special populations with candidaemia and/or invasive candidiasis · Oliver A. Cornely · 2025 · 16 citations · Cited by this paper
  28. Reappraisal of intra-abdominal candidiasis: insights from peritoneal fluid analysis · Emmanuel Novy · 2023 · 13 citations · Cited by this paper
  29. Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation · Matteo Bassetti · 2024 · 9 citations · Cited by this paper
  30. Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofungin · Àlex Soriano · 2024 · 9 citations · Cited by this paper
  31. Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review · Marco Marotta Pais · 2025 · 8 citations · Cited by this paper
  32. Rezafungin Utilisation in Real Life— FungiScope Results From Europe and the United States · Ilana Reinhold · 2025 · 8 citations · Cited by this paper
  33. Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study · Davide Fiore Bavaro · 2025 · 4 citations · Cited by this paper
  34. Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real‐World Clinical Practice · Jorge Boán · 2026 · 2 citations · Cited by this paper
  35. Real-world experience with rezafungin for the treatment of biofilm-forming Candida infections · Marta Albanell‐Fernández · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)